Evidence map›Paper›PMID 39947158›Full record

SynthesisDementia and geriatric cognitive disorders2025

Diversity in United States Dementia Prevention Trials: An Updated Systematic Review of Eligibility Criteria and Recruitment Strategies.

Najoua Lazaar, Sabine E Van Beek, Awaale F Rirash, Janne M Papma, Jaime Perales-Puchalt, Ashley R Shaw, Eric D Vidoni, Sanne Franzen

Abstract readSystematic Review
In one paragraph

Synthesis in Dementia and geriatric cognitive disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Najoua LazaarDepartment of Neurology and Alzheimer Center, Erasmus MC University Medical Center, Rotterdam, The Netherlands, n.lazaar@erasmusmc.nl.
Sabine E Van BeekDepartment of Neurology and Alzheimer Center, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Awaale F RirashDepartment of Neurology and Alzheimer Center, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Janne M PapmaDepartment of Neurology and Alzheimer Center, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Jaime Perales-PuchaltDepartment of Neurology, University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, Kansas, USA.
Ashley R ShawDepartment of Neurology, University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, Kansas, USA.
Eric D VidoniDepartment of Neurology, University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, Kansas, USA.
Sanne FranzenDepartment of Neurology and Alzheimer Center, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Funding

University of Kansas Alzheimer's Disease Research Center (KU ADRC)P30AG072973 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Robyn A Honea · 2021 to 2026
$25.3M
Differential Effects of Exercise Modality on Cognition and Brain in Older AdultsR01AG070036 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SZABO-REED, AMANDA N., VIDONI, ERIC DENNIS · 2021 to 2025
$6.9M
Feasibility of a Novel Systems Approach for Improving Utilization of Alzheimer's Disease Services Among Latinos Attending Primary Care PracticesK01MD014177 · NIMHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI PERALES PUCHALT, JAIME · 2020 to 2024
$571k
Brain Healthy Soul Food Diet Intervention Among Older African AmericansK01AG072034 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SHAW, ASHLEY RICHELLE · 2021 to 2024
$507k
NIA NIH HHS K01 AG072034NIA NIH HHS P30 AG072973NIA NIH HHS R01 AG070036NIMHD NIH HHS K01 MD014177
6 · The paper itself

Abstract

<p>Introduction: Given the elevated dementia risk in underrepresented demographic groups in the USA - particularly in Latino and Non-Latino Black individuals compared to Non-Latino White individuals - it is vital that these groups are well-represented in dementia prevention research. Eligibility criteria and recruitment strategies may play a key role in promoting participant diversity. The aim of this review was to examine eligibility criteria and recruitment strategies in US dementia prevention trials in light of participant diversity.

methodsA systematic review was conducted using Medline (including PubMed), Embase, Cochrane Library, and CINAHL. We explored the percent White participants for trials using versus not using a specific eligibility criterion or recruitment strategy using Hodges-Lehmann median difference estimation.

resultsOf forty-four studies meeting the inclusion criteria, twenty-seven reported on racial/ethnic diversity. Analyses demonstrated that criteria regarding cardiovascular disease, pulmonary disease, hearing impairment, and sedentary lifestyle were associated with relatively high participant diversity, while gastro-intestinal/liver disease, motivation to participate, and language proficiency criteria were associated with relatively little diversity. Information on recruitment strategies was often lacking. Three studies described recruitment efforts explicitly aimed at increasing diversity. Recruitment strategies associated with relatively high racial/ethnic diversity included recruitment via referral/word-of-mouth, television/radio advertising, and recruitment at church.

conclusionEligibility criteria could be improved by revisiting and revising how they are defined (e.g., motivation to participate). Regarding recruitment, several recommendations are provided, including (1) lifting barriers to study participation (e.g., through reimbursement), (2) collaborating with community partners, and (3) formally studying the effectiveness of recruitment strategies. </p>.

Indexed as

Clinical Trials as TopicCultural DiversityDementiaEligibility DeterminationPatient SelectionEthnicityHumansUnited StatesClinical trial protocolsCultural diversityEthnic groupsPatient recruitmentRandomized controlled trials

Identifiers

PMID39947158
PMCPMC12366532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.